arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

ALUMIS INC.

ALMS
$27.53 ▼ -0.25 (-0.90%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
14 Visible periods
23 Metrics
Peer-ranked Benchmarks
Price Chart
31
Health
Poor
Bearish
auto_awesome

Analytical Summary

ALUMIS INC. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $3.4B
Dividend Yield
Revenue Growth -90.0%
Op. Margin
ROIC -13.7%
FCF / Share $-0.70
Trailing P/E
Price / Book 6.1x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

14-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$1.74M
↓ -90.0%
Net Income Profit after all expenses
$-93.05M
↑ +6.0%
FCF / Share Free cash flow per share
$-0.70
↑ +52.9%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns
11
Cash Quality
80

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 4 years · 14 quarters